AgomAb Therapeutics NV

Last updated September 27, 2026
Favorite this organization

Organization details

Legal name
AgomAb Therapeutics NV
Ownership
Public
Status
Active
SIC code
2836 — Biological Products, (No Diagnostic Substances)
Jurisdiction of incorporation
Belgium
Headquarters city
Antwerpen
Headquarters country
Belgium
Fiscal year end
December
Ticker symbol
AGMB
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0002020932

Board of directors

Follow this board

Chief executives

Tim Jasper Knotnerus · Chief Executive Officer
Since March 2026

Board connections

3 of this board's directors also sit on 3 other boards.

Network of AgomAb Therapeutics NV's board connections Dianthus Therapeutics Inc. Dianthus Therapeutics... Evommune Inc. Evommune Inc. Tempus AI Inc. Tempus AI Inc. David R. Epstein David R. Epstein Marino Garcia Marino Garcia Weegen Felice Isabel Verduyn-van Weegen Felice Isabel... AgomAb Therapeutics NV
Shared director Other board Same sector

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.